{"cluster": 45, "subcluster": 0, "abstract_summ": "There is some evidence that Covid 19 pneumonia is associated with prothrombotic status and increased risk of venous thromboembolic events (deep venous thrombosis and pulmonary embolism).They were all males, with a mean age of 70.3 years (range 58\u201384); traditional risk factors for venous thromboembolism were identified in the majority of patients with pulmonary embolism, however not differently from those without pulmonary embolism.CASE PRESENTATION We describe the clinical course of three patients admitted with SARS-CoV-2 infection and respiratory distress, where pulmonary embolism was detected during the course of the hospitalisation.The pathophysiology in COVID-19 patients is thought to relate to a thromboinflammatory state within the pulmonary vasculature, triggered by the infection, but other risk factors such as reduced mobility, prolonged immobilisation and dehydration are likely to contribute.The present article describes three cases of patients with SARS-CoV-2 pneumonia and late occurrence of pulmonary embolism.", "title_summ": "Thrombus in Transit and Impending Pulmonary Embolism Detected on POCUS in a Patient with COVID-19 PneumoniaArterial Mesenteric Thrombosis as a Complication of SARS-CoV-2 InfectionDeep Vein Thrombosis and Pulmonary Embolism: Two Complications of COVID-19 Pneumonia?Acute pulmonary embolism in COVID-19 disease: Preliminary report on seven patientsPulmonary embolism in cases of COVID-19.[Late occurrence of pulmonary embolsim in SARS-CoV-2 pneumonia: a case series].Detection of Pulmonary Embolism in Returning Travelers with Hypoxemic Pneumonia due to COVID-19 in Reunion Island.Pulmonary embolism in acute medicine: a case-based review incorporating latest guidelines in the COVID-19 era.", "title_abstract_phrases": "Further research is required to establish appropriate clinical management guidelines for prevention of thromboembolic complications in COVID-19.[Late occurrence of pulmonary embolsim in SARS-CoV-2 pneumonia: a case series].Several studies suggested that the acute phase of SARS-CoV-2 infection may be associated with a hypercoagulable state and increased risk for venous thromboembolism but the incidence of thrombotic complications in the late phase of the disease is currently unknown.Computed tomographic findings ranged from massive acute pulmonary embolism to a segmental or sub-segmental pattern; furthermore, thrombosis of sub-segmental pulmonary arteries within lung infiltrates were occasionally seen, suggesting local mechanisms.The pathophysiology in COVID-19 patients is thought to relate to a thromboinflammatory state within the pulmonary vasculature, triggered by the infection, but other risk factors such as reduced mobility, prolonged immobilisation and dehydration are likely to contribute.Acute pulmonary embolism in COVID-19 disease: Preliminary report on seven patientsThere is some evidence that Covid 19 pneumonia is associated with prothrombotic status and increased risk of venous thromboembolic events (deep venous thrombosis and pulmonary embolism).Several societies have released comprehensive guidelines emphasising the importance of risk stratification in patients with acute pulmonary embolism."}